How low is the α/β ratio for prostate cancer?

被引:272
作者
Wang, JZ [1 ]
Guerrero, M [1 ]
Li, XA [1 ]
机构
[1] Univ Maryland, Dept Radiat Oncol, Baltimore, MD 21201 USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2003年 / 55卷 / 01期
关键词
prostate cancer; radiotherapy; linear-quadratic model; tumor repopulation;
D O I
10.1016/S0360-3016(02)03828-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: It has been suggested recently that the alpha/beta ratio for human prostate cancer is low (around 1.5 Gy), and much debate on the evidence for such a low value is ongoing. Analyses reported so far ignored the contribution of tumor repopulation. Extremely low a values and unrealistic cell numbers of tumor clonogens are found in these studies. In this paper, we present a comprehensive analysis of the updated clinical data to derive a self-consistent set of parameters for the linear-quadratic (LQ) model. Methods and Materials: The generalized LQ model, considering the effects of dose rate, sublethal damage repair, and clonogenic proliferation, was used to analyze the recently reported clinical data for prostate cancer using either external-beam radiotherapy or brachytherapy. Three LQ parameters, alpha, alpha/beta, and the repair time, were determined based on the clinical finding that the external-beam radiotherapy and the 125 1 and 103 Pd permanent implants are biologically equivalent. The tumor control probability model was used also to analyze the clinical data to obtain an independent relationship of alpha/beta vs. a and to estimate clonogenic cell numbers for patients in different risk groups. Results: Based on the analysis of clinical data and a consideration of repopulation effect, we have derived a self-consistent set of LQ parameters for prostate cancer: alpha = 0.15 +/- 0.04 Gy(-1), alpha/beta = 3.1 beta+/- 0.5 Gy. Our analysis indicates the half-time of sublethal damage repair to be in the range from 0 to 90 min with a best estimate of 16 min. The best estimate of clonogenic cell numbers in prostate tumors is found to range from 106 to 107 according to the patient risk level. These values are more realistic than those derived previously (only 10-100). Conclusions: The effect of tumor repopulation is not negligible in determining the LQ parameters for prostate cancer, especially for the low-dose-rate permanent implants. Analysis of clinical data for prostate cancer with corrections for damage repair and repopulation effects results in a low alpha/beta ratio of 3.1 Gy. Unrealistic clonogenic cell numbers and extremely small values of a reported in the literature can be resolved by correcting for repopulation effect. The LQ parameters derived presently from the clinical data are consistent with reports of intrinsic radiosensitivity in vitro. (C) 2003 Elsevier Science Inc.
引用
收藏
页码:194 / 203
页数:10
相关论文
共 38 条
[11]   Sensitivity of human prostatic carcinoma cell lines to low dose rate radiation exposure [J].
Deweese, TL ;
Shipman, JM ;
Dillehay, LE ;
Nelson, WG .
JOURNAL OF UROLOGY, 1998, 159 (02) :591-598
[12]  
Duchesne GM, 1999, INT J RADIAT ONCOL, V44, P747
[13]   Is α/β for prostate tumors really low? [J].
Fowler, J ;
Chappell, R ;
Ritter, M .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 50 (04) :1021-1031
[14]   The prospects for new treatments for prostate cancer [J].
Fowler, JF ;
Chappell, RJ ;
Ritter, MA .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 52 (01) :3-5
[15]   THE LINEAR-QUADRATIC FORMULA AND PROGRESS IN FRACTIONATED RADIOTHERAPY [J].
FOWLER, JF .
BRITISH JOURNAL OF RADIOLOGY, 1989, 62 (740) :679-694
[16]   Optimization of conformal radiation treatment of prostate cancer: Report of a dose escalation study [J].
Hanks, GE ;
Schultheiss, TE ;
Hanlon, AL ;
Hunt, M ;
Lee, WR ;
Epstein, BE ;
Coia, LR .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 37 (03) :543-550
[17]   Dose selection for prostate cancer patients based on dose comparison and dose response studies [J].
Hanks, GE ;
Hanlon, AL ;
Pinover, WH ;
Horwitz, EM ;
Price, RA ;
Schultheiss, T .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 46 (04) :823-832
[18]   A comment on proliferation rates in human prostate cancer [J].
Haustermans, K ;
Fowler, JF .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 48 (01) :303-303
[19]  
Kampinga HH, 1997, INT J RADIAT BIOL, V72, P293, DOI 10.1080/095530097143284
[20]   Optimal radiotherapy for prostate cancer: Predictions for conventional external beam, IMRT, and brachytherapy from radiobiologic models [J].
King, CR ;
DiPetrillo, TA ;
Wazer, DE .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 46 (01) :165-172